CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program

NEXT STORY
Endoscope Market
PREV STORY
Cerecor and Aevi Genomic Medicine Complete Merger
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ABLYNX TO PRESENT AT THE 35th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] will present at the 35th Annual J.P. Morgan ...

author_avatar
NASDAQ Market News

Well-Known Spanish Immersion Summer Program Now Accepting Applications in the San Francisco Bay Area

SAN JOSE, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Amigos de las Américas, a ...

author_avatar
NASDAQ Market News

ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights

-- Phase III ADVOCATE trial of avacopan in treatment of ANCA vasculitis nears 75% ...

author_avatar
NASDAQ Market News